IN141109B - - Google Patents

Info

Publication number
IN141109B
IN141109B IN1357/CAL/75A IN1357CA1975A IN141109B IN 141109 B IN141109 B IN 141109B IN 1357CA1975 A IN1357CA1975 A IN 1357CA1975A IN 141109 B IN141109 B IN 141109B
Authority
IN
India
Application number
IN1357/CAL/75A
Other languages
English (en)
Inventor
J Danilewicz
J Kemp
J Wright
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IN141109B publication Critical patent/IN141109B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44Iso-indoles; Hydrogenated iso-indoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IN1357/CAL/75A 1972-09-09 1975-07-11 IN141109B (member.php)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4199272A GB1383409A (en) 1972-09-09 1972-09-09 Derivatives of 2-amino- and 4-amino-quinazoline and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
IN141109B true IN141109B (member.php) 1977-01-22

Family

ID=10422335

Family Applications (2)

Application Number Title Priority Date Filing Date
IN1920/CAL/73A IN139088B (member.php) 1972-09-09 1973-08-21
IN1357/CAL/75A IN141109B (member.php) 1972-09-09 1975-07-11

Family Applications Before (1)

Application Number Title Priority Date Filing Date
IN1920/CAL/73A IN139088B (member.php) 1972-09-09 1973-08-21

Country Status (17)

Country Link
US (1) US3960861A (member.php)
JP (1) JPS4985078A (member.php)
AR (1) AR203373A1 (member.php)
AT (1) AT330785B (member.php)
BE (1) BE804558A (member.php)
CA (1) CA995673A (member.php)
DE (2) DE2366106C2 (member.php)
DK (1) DK131725C (member.php)
ES (1) ES418612A1 (member.php)
FR (1) FR2198751B1 (member.php)
GB (1) GB1383409A (member.php)
IE (1) IE38318B1 (member.php)
IN (2) IN139088B (member.php)
LU (1) LU68373A1 (member.php)
NL (1) NL161152C (member.php)
SU (1) SU555850A3 (member.php)
ZA (1) ZA735660B (member.php)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4044136A (en) * 1972-09-09 1977-08-23 Pfizer Inc. Aminoquinazoline therapeutic agents
GR79603B (member.php) * 1982-07-24 1984-10-31 Pfizer
DE3464247D1 (de) * 1983-06-28 1987-07-23 Ciba Geigy Ag Chromogenic quinazoline compounds
BR9107070A (pt) * 1990-11-06 1994-05-31 Pfizer Processo para a preparação de derivados de quinazolina uteis para melhorar a atividade antitumoral.
KR0144833B1 (ko) * 1992-12-28 1998-07-15 김태훈 신규의 퀴나졸린 유도체 및 그의 제조방법
DE4338396A1 (de) * 1993-11-10 1995-05-11 Basf Ag N-Substituierte Azabicycloalkan-Derivate, ihre Herstellung und Verwendung
IT1286302B1 (it) * 1996-04-10 1998-07-08 Rotta Research Lab Chinazoline-4-amino-2-(piperidino-1-il-4-sostituite) ad attivita' anti-ipertensiva, procedimento per la loro preparazione e loro uso
IN188411B (member.php) 1997-03-27 2002-09-21 Yuhan Corp
KR100272471B1 (ko) 1998-11-17 2000-11-15 김선진 신규의 피리미딘 유도체 및 그의 제조방법
US6900220B2 (en) 2001-01-02 2005-05-31 Syntex (U.S.A.) Llc Quinazolone derivatives as alpha 1A/B adrenergic receptor antagonists
EP1560816A1 (en) * 2002-07-05 2005-08-10 F. Hoffmann-La Roche Ag Quinazoline derivatives
US7947689B2 (en) * 2006-08-04 2011-05-24 Merz Pharma Gmbh & Co. Kgaa Substituted pyrazolo[1,5-a]pyrimidines as metabotropic glutamate receptor modulators
US8871756B2 (en) * 2011-08-11 2014-10-28 Hoffmann-La Roche Inc. Compounds for the treatment and prophylaxis of Respiratory Syncytial Virus disease
WO2015018797A2 (en) * 2013-08-05 2015-02-12 Haplogen Gmbh Antiviral compounds
AR099134A1 (es) * 2014-01-24 2016-06-29 Hoffmann La Roche Procedimiento para la preparación de n-[(3-aminooxetán-3-il)metil]-2-(1,1-dioxo-3,5-dihidro-1,4-benzotiazepín-4-il)-6-metil-quinazolín-4-amina
JP6749343B2 (ja) 2015-05-20 2020-09-02 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 脊髄性筋萎縮症を処置するための化合物
EP3322704B1 (en) 2015-07-16 2019-11-27 H. Hoffnabb-La Roche Ag Crystalline form of n-[(3-amino-3-oxetanyl)methyl]-2-(2,3-dihydro-1,1-dioxido-1,4-benzothiazepin-4(5h)-yl)-6-methyl-4-quinazolinamine for the treatment of respiratory syncytial virus (rsv) infections
CA3002494C (en) 2015-11-12 2021-01-12 F. Hoffmann-La Roche Ag Compositions for treating spinal muscular atrophy
CN108137579B (zh) 2015-12-10 2022-01-07 豪夫迈·罗氏有限公司 桥连哌啶衍生物
WO2017100726A1 (en) 2015-12-10 2017-06-15 Ptc Therapeutics, Inc. Methods for treatng huntington's disease
FR3061494B1 (fr) 2016-12-29 2020-07-03 Arkema France Procede de synthese de dithiocarbamates cycliques fonctionnalises
BR112019025740A2 (pt) 2017-06-05 2020-06-23 Ptc Therapeutics, Inc. Compostos para tratar a doença de huntington
US11382918B2 (en) 2017-06-28 2022-07-12 Ptc Therapeutics, Inc. Methods for treating Huntington's Disease
MX2019015580A (es) 2017-06-28 2020-07-28 Ptc Therapeutics Inc Metodos para tratar la enfermedad de huntington.
SG11202009212WA (en) 2018-03-27 2020-10-29 Ptc Therapeutics Inc Compounds for treating huntington's disease
JP7421507B2 (ja) 2018-06-27 2024-01-24 ピーティーシー セラピューティクス, インコーポレイテッド ハンチントン病を処置するためのヘテロ環式およびヘテロアリール化合物
EP3814360B8 (en) 2018-06-27 2024-11-06 PTC Therapeutics, Inc. Heteroaryl compounds for treating huntington's disease
BR112020026534A2 (pt) 2018-06-27 2021-03-23 Ptc Therapeutics, Inc. Compostos de heteroarila para o tratamento da doença de huntington

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2945859A (en) * 1960-07-19 Diaminoquinazolines and method of
BE501634A (member.php) * 1950-03-02
US3155572A (en) * 1959-04-13 1964-11-03 Merck & Co Inc Compositions and methods for treating coccidiosis
GB1062357A (en) * 1965-03-23 1967-03-22 Pfizer & Co C Quinazolone derivatives
GB1131126A (en) * 1966-03-10 1968-10-23 Pfizer Ltd 2-vinyl-1,4-dihydroquinazoline derivatives
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
US3637701A (en) * 1969-03-03 1972-01-25 Sandoz Ag Certain nitrate derivatives of 4-aminoquinazolines
US3663706A (en) * 1969-09-29 1972-05-16 Pfizer Use of 2,4-diaminoquinazolines as hypotensive agents
US3669968A (en) * 1970-05-21 1972-06-13 Pfizer Trialkoxy quinazolines

Also Published As

Publication number Publication date
NL161152B (nl) 1979-08-15
AU5960673A (en) 1975-02-27
NL7312350A (member.php) 1974-03-12
US3960861A (en) 1976-06-01
LU68373A1 (member.php) 1975-05-21
GB1383409A (en) 1974-02-12
DE2366106B1 (de) 1979-06-21
SU555850A3 (ru) 1977-04-25
BE804558A (fr) 1974-03-06
IE38318B1 (en) 1978-02-15
DE2366106C2 (de) 1980-02-14
NL161152C (nl) 1980-01-15
DK131725C (da) 1976-01-26
IN139088B (member.php) 1976-05-08
DE2345064B2 (de) 1979-03-08
DE2345064A1 (de) 1974-04-11
AR203373A1 (es) 1975-09-08
FR2198751A1 (member.php) 1974-04-05
JPS4985078A (member.php) 1974-08-15
DK131725B (da) 1975-08-25
FR2198751B1 (member.php) 1977-01-28
IE38318L (en) 1974-03-09
DE2345064C3 (de) 1979-10-25
ES418612A1 (es) 1976-07-16
CA995673A (en) 1976-08-24
ZA735660B (en) 1974-07-31
ATA774573A (de) 1975-10-15
AT330785B (de) 1976-07-26

Similar Documents

Publication Publication Date Title
HU166746B (member.php)
JPS4894426U (member.php)
JPS48113433U (member.php)
CH567880A5 (member.php)
CH560498A5 (member.php)
CH560843A5 (member.php)
CH561030A5 (member.php)
CH561041A5 (member.php)
CH561588A5 (member.php)
CH561888A5 (member.php)
CH562025A5 (member.php)
CH562149A5 (member.php)
CH562394A5 (member.php)
CH563006A5 (member.php)
CH563059A5 (member.php)
CH563624A5 (member.php)
CH563955A5 (member.php)
CH563970A5 (member.php)
CH564084A5 (member.php)
CH564490A5 (member.php)
CH564806A5 (member.php)
CH564894A5 (member.php)
CH564939A5 (member.php)
CH565273A (member.php)
CH565333A5 (member.php)